An in vitro evaluation of inflammation response of titanium functionalized with heparin/fibronectin complex

Cytokine

Volumn 56, Issue 2, 2011, Pages 208-217

  Li, Guicai ^a   Yang, Ping ^a   Guo, Xiang ^a   Huang, Nan ^a   Shen, Ru ^a  

^a SOUTHWEST JIAOTONG UNIVERSITY   (China)

Author keywords

Coimmobilization; Fibronectin; Heparin; Inflammation; Titanium

Indexed keywords

FIBRONECTIN; HEPARIN; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TITANIUM DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CHEMICAL COMPOSITION; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INFLAMMATION; INFRARED SPECTROSCOPY; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; UMBILICAL VEIN ENDOTHELIAL CELL;

FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; HEPARIN; HUMANS; INFLAMMATION; MACROPHAGES; MICROSCOPY, ELECTRON, SCANNING; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TITANIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053338519     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.06.020     Document Type: Article

References (69)

1. Gong F.R., Cheng X.Y., Wang S.F., Zhao Y.C., Gao Y., Cai H.B. Heparin-immobilized polymers as on-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents. Acta Biomater 2010, 6:534-546.
2. Zhu A.P., Zhang M., Wu J., Shen J. Covalent immobilization of chitosan/heparin mixture with a photosensitive hetero-bifunctional crosslinking reagent on PLA surface. Biomaterials 2002, 23:4657-4665.
3. Yin Y.B., Wise S.G., Nosworthy N.G., Waterhouse A., Bax D.V., Youssef H., et al. Covalent immobilisation of tropoelastin on a plasma deposited interface for enhancement of endothelialisation on metal surfaces. Biomaterials 2009, 30:1675-1681.
4. Hersel U., Dahmen C., Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24:4385-4415.
5. Guarnieri D., De Capua A., Ventre M., Borzacchiello A., Pedone C., Marasco D., et al. Covalently immobilized RGD gradient on PEG hydrogel scaffold influences cell migration parameters. Acta Biomater 2010, 6:2532-2539.
6. Campoccia D., Montanaro L., Arciola C.R. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 2006, 27:2331-2339.
7. Fukano Y., Knowles N.G., Usui M.L., Underwood R.A., Hauch K.D., Marshall A.J., et al. Characterization of an in vitro model for evaluating the interface between skin and percutaneous biomaterials. Wound Repair Regen 2006, 14:484-491.
8. Basta G., Sarchielli P., Luca G., Racanicchi L., Nastruzzi C., Guido L., et al. Optimized parameters for microencapsulation of pancreatic islet cells: an in vitro study clueing on islet graft immunoprotection in type 1 diabetes mellitus. Transpl Immunol 2004, 13:289-292.
9. Meinel L., Hofmann S., Karageorgiou V., Kirker-Head C., McCool J., Gronowicz G., et al. The inflammatory responses to silk films in vitro and in vivo. Biomaterials 2005, 26:147-155.
10. Anderson J.M. Mechanisms of inflammation and infection with implanted devices. Cardiovasc Pathol 1993, 2:33S-41S.
11. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883-899.
12. Lin C.W., Chen L.J., Lee P.L., Lee C.I., Lin J.C., Chiu J.J. The inhibition of TNF-alpha-induced E-selectin expression in endothelial cells via the JNK/NF-kappaB pathways by highly N-acetylated chitooligosaccharides. Biomaterials 2007, 28:1355-1366.
13. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. N Eng J Med 1998, 338:436-445.
14. Gorzelanny C., Pöppelmann B., Pappelbaum K., Moerschbacher B.M., Schneider S.W. Human macrophage activation triggered by chitotriosidase-mediated chitin and chitosan degradation. Biomaterials 2010, 33:8556-8563.
15. Bailey L.O., Lippiatt S., Biancanello F.S., Ridder S.D., Washburn N.R. The quantification of cellular viability and inflammatory response to stainless steel alloys. Biomaterials 2005, 26:5296-5302.
16. Rudra J.S., Tripathi P.K., Hildeman D.A., Jung J.P., Collier J.H. Immune responses to coiled coil supramolecular biomaterials. Biomaterials 2010, 32:8475-8483.
17. Schutte R.J., Amon A.P., Reichert W.M. Cytokine profiling using monocytes/macrophages cultured on common biomaterials with a range of surface chemistries. J Biomed Mater Res A 2009, 88:128-139.
18. Schutte R.J., Xie L., Klitzman B., Reichert W.M. In vivo cytokine-associated responses to biomaterials. Biomaterials 2009, 30:160-168.
19. Refai A.K., Textor M., Brunette D.M., Waterfield J.D. Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines. J Biomed Mater Res A 2004, 70:194-205.
20. Cardona M.A., Simmonsm R.L., Kaplan S.S. TNF and IL-1 generation by human monocytes in response to biomaterials. J Biomed Mater Res 1992, 26:851-859.
21. Ding T.T., Sun J., Zhang P. Immune evaluation of biomaterials in TNF-α and IL-1β at mRNA level. J Mater Sci Mater Med 2007, 18:2233-2236.
22. McKellar G.E., McCarey D.W., Sattar N., McInnes I.B. Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 2009, 6:410-417.
23. Rae T. A study on the effects of particulate metals of orthopaedic interest on murine macrophages in vitro. J Bone Joint Sur Br 1975, 57:444-450.
24. Ramstedt S., Palmquist A., Johansson A., Breding K., Engqvist H., Thomsen P. Inflammatory response to injectable biomaterials for stabilisation of vertebral compression fractures. Trends Biomater Artif Organs 2010, 24:1-10.
25. Mukaida N., Harada A., Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 1998, 9:9-23.
26. Ding T.T., Sun J., Zhang P. Study on MCP-1 related to inflammation induced by biomaterials. Biomed Mater 2009, 4:35-39.
27. Ding T.T., Sun J., Zhang P. MCP-1 expression associated with inflammation and biomaterials. Adv Mater Res 2008, 47:1423-1426.
28. Delaleu N., Bickel M. Interleukin-1 beta and interleukin-18: regulation and activity in local inflammation. Periodontol 2004, 35:42-52.
29. Santos T.C., Marques A.P., Höring B., Martins A.R., Tuzlakoglu K., Castro A.G., et al. In vivo short-term and long-term host reaction to starch-based scaffolds. Acta Biomater 2010, 11:4314-4326.
30. Wooley P.H., Morren R., Andary J., Suda S., Yang S.Y., Mayton L., et al. Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 2002, 23:517-526.
31. Luthen F., Lange R., Becker P., Rychly J., Beck U., Nebe J.G. The influence of surface roughness of titanium on beta1 and beta3-integrin adhesion and the organization of fibronectin in human osteoblastic cells. Biomaterials 2005, 26:2423-2440.
32. Murugesan G., Rani S., Ransohoff R.M., Marchant R.E., Marchant K.K. Endothelial cell expression of monocyte chemotactic protein-1, tissue factor, and thrombomodulin on hydrophilic plasma polymers. J Biomed Mater Res 2000, 49:396-408.
33. Wang X.D., Lennartz M.R., Loegering D.J., Stenken J.A. Multiplexed cytokine detection of interstitial fluid collected from polymeric hollow tube implants - a feasibility study. Cytokine 2008, 43:15-19.
34. Li G.C., Zhang F.M., Liao Y.Z., Yang P., Huang N. Coimmobilization of heparin/fibronectin mixture on titanium surfaces and their blood compatibility. Colloid Surface B 2010, 81:255-262.
35. Suri C.R., Mishra G.C. Activating piezoelectric crystal surface by silanization for microgravimetric immunobiosensor application. Biosens Bioelectron 1996, 11:1199-1205.
36. Smith R.K., Mallia A.K., Hermanson G.T. Colorimetric method for the assay of heparin content in immobilized heparin preparations. Anal Biochem 1980, 109:466-473.
37. Chen J.Y., Wan G.J., Leng Y.X., Yang P., Sun H., Wang J., et al. Behavior of cultured human umbilical vein endothelial cells on titanium oxide films fabricated by plasma immersion ion implantation and deposition. Surf Coat Technol 2004, 186:270-276.
38. Byun Y., Jacobs H.A., Feijen J., Kim S.W. Effect of fibronectin on the binding of antithrombin III to immobilized heparin. J Biomed Mater Res 1996, 30:95-100.
39. Toworfe G.K., Bhattacharyya S., Composto R.G., Adams C.S., Shapiro I.M., Ducheyne P. Effect of functional end groups of silane self-assembled monolayer surfaces on apatite formation, fibronectin adsorption and osteoblast cell function. J Tissue Eng Regen Med 2009, 3:26-36.
40. Futami T., Fujii N., Ohnishi H., Taguchi N., Kusakari H., Ohshima H., et al. Tissue response to titanium implants in the rat maxilla: ultrastructural and histochemical observations of the bone-titanium interface. J Periodontol 2000, 71:287-298.
41. Julow J., Ishii M., Iwabuchi T. Scanning electron microscopy of the subarachnoid macrophages after subarachnoid haemorrhage, and their possible role in the formation of subarachnoid fibrosis. Acta Neurochir 1979, 50:273-280.
42. Yang D., Jones K.S. Effect of alginate on innate immune activation of macrophages. J Biomed Mater Res A 2009, 90:411-418.
43. Lee S., Shin S., Im Y.M., Song J., Kang S.S., Nam T.H., et al. Analysis on migration and activation of live macrophages on transparent flat and nano structured titanium. Acta Biomater 2011, 10.1016/j.actbio.2011.01.00.
44. Tapper H. The secretion of performed granules by macrophages and neutrophils. J Leukoc Biol 1996, 59:613-622.
45. Anderson J.M. Biological responses to materials. Annu Rev Mater Res 2001, 31:81-110.
46. Cavaillon J.M. Cytokines and macrophages. Biomed Pharmacother 1994, 48:445-453.
47. Jenney C.R., Anderson J.M. Adsorbed IgG: a potent adhesive substrate for human macrophages. J Biomed Mater Res 2000, 50:281-290.
48. Kao W.J., Lee D., Schense J.C., Hubbell J.A. Fibronectin modulates macrophage adhesion and FBGC formation: the role of RGD, PHSRN, and PRRARV domains. J Biomed Mater Res 2001, 55:79-88.
49. Anderson J.M., Miller K.M. Biomaterial biocompatibility and the macrophage. Biomaterials 1984, 6:6-10.
50. Cardona M.A., Simmons R.L., Kaplan S.S. TNF and IL-1 generation by human monocytes in response to biomaterials. J Biomed Mater Res 1996, 26:851-859.
51. Chang D.T., Jones J.A., Meyerson H., Colton E., Kwon I.I.K., Matsuda T., et al. Lymphocyte/macrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production. J Biomed Mater Res A 2008, 87:676-687.
52. Dadsetan M., Jones J.A., Hiltner A., Anderson J.M. Surface chemistry mediates adhesive structure, cytoskeletal organization, and fusion of macrophages. J Biomed Mater Res A 2004, 71:439-448.
53. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998, 394:894-897.
54. Hartung D., Petrov A., Haider N., Fujimoto S., Blankenberg F., Fujimoto A., et al. Radiolabeled monocyte chemotactic protein 1 for the detection of inflammation in experimental atherosclerosis. J Nucl Med 2007, 48:1816-1821.
55. Andersson J.M., Suska F., Johansson A., Berglin M., Emanuelsson L., Elwing H., et al. Effect of molecular mobility of polymeric implants on soft tissue reactions: an in vivo study in rats. J Biomed Mater Res A 2008, 84:652-660.
56. Anderson J.M. Inflammation and the foreign body response. Probl Gen Surg 1994, 11:147-160.
57. Li Q.K., Hata A., Kosugi C., Kataoka N., Funaki M. The density of extracellular matrix proteins regulates inflammation and insulin signaling in adipocytes. FEBS 2010, 19:4145-4150.
58. Black S.C., Gralinski M.R., Friedrichs G.S., Kilgore K., Driscoll E.M., Lucchesi B.R. Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury. Cardiovasc Res 1995, 29:629-636.
59. Paparella D., Radi O.A., Meng Q.H., Venner T., Teoh K., Young E. The effects of high-dose heparin on inflammatory andcoagulation factors following cardiopulmonary bypass. Blood Coagul Fibrinolysis 2005, 16:323-328.
60. Young E. The anti-inflammatory effects of heparin and related compounds. Thromb Res 2008, 122:743-752.
61. Elsayed E., Becker R.C. The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development. J Thromb Thrombolysis 2003, 15:11-18.
62. Wang L.C., Brown J.C., Varki A., Esko J.D. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest 2002, 110:127-136.
63. Nelson R.M., Cecconi O., Roberts W.G., Aruffo A., Lindhardt R.J., Bevilacqua M.P. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood 1993, 82:3253-3258.
64. Lever R., Hoult J.R.S., Page C.P. The effects of heparin and related molecules upon the adhesion of human polymorphonuclear leukocytes to vascular endothelium in vitro. Br J Pharmacol 2000, 129:533-540.
65. Trinchieri G., Sher A. Cooperation of toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007, 7:179.
66. Collier T.O., Anderson J.M. Protein and surface effects on monocyte and macrophage adhesion, aturation, and survival. J Biomed Mater Res 2002, 60:487-496.
67. Bader R.A., Wagoner K.L. Modulation of the response of rheumatoid arthritis synovial fibroblasts to proinflammatory stimulants with cyclic tensile strain. Cytokine 2010, 51:35-41.
68. Holt D.J., Chamberlain L.M., Grainger D.W. Cell-cell signaling in co-cultures of macrophages and fibroblasts. Biomaterials 2010, 36:9382-9394.
69. Petaja J. Inflammation and coagulation: an overview. Thromb Res 2011, 127:S34-S37.